Publications
Publications
Show Results For
-
All HBS Web
(1,665)
- Faculty Publications (249)
Page 1 of
249
Results
→
- January 2023
- Teaching Note
The Opioid Settlement and Executive Pay at AmerisourceBergen
By: Suraj Srinivasan and Li-Kuan Ni
Teaching Note for HBS Case No 122-014. In 2020, AmerisourceBergen Corporation, a Fortune 50 company in the drug distribution industry, agreed to settle thousands of lawsuits filed nationwide against the company for its opioid distribution practices that critics alleged...
View Details
Keywords:
Opioids;
Shareholder Activism;
Investment Activism;
Corporate Accountability;
Corporate Governance;
Governance Compliance;
Governance Controls;
Executive Compensation;
Risk Management;
Corporate Social Responsibility and Impact;
Business and Shareholder Relations;
Business and Stakeholder Relations;
Distribution Industry;
Health Industry;
Pharmaceutical Industry;
United States;
West Virginia;
Tennessee;
Ohio;
Pennsylvania
- November 2022
- Case
Para: Pay Transparency and Gig Drivers’ Rights
By: Christopher Stanton and George Gonzalez
The case presents the founding vision and early days of a young startup that seeks to empower delivery drivers with tools and transparency. The company's flagship mobile app has been taken up by tens of thousands of delivery drivers across major U.S. cities who use it...
View Details
- 2022
- Working Paper
How Do Investors Value ESG?
By: Malcolm Baker, Mark Egan and Suproteem K. Sarkar
Environmental, social, and governance (ESG) objectives have risen to near the top of the agenda for corporate executives and boards, driven in large part by their perceptions of shareholder interest. We quantify the value that shareholders place on ESG using a revealed...
View Details
- October 2022
- Case
mPharma: Scaling Access to Affordable Primary Care in Africa
By: Regina E. Herzlinger and Ben Creo
mPharma CEO Greg Rockson is attempting to create the largest pan-African primary healthcare company. He must evaluate a three-year strategy potentially involving three key components: a rapid and extensive expansion of the company's network of 600 retail pharmacies in...
View Details
Keywords:
Africa;
Pharmaceutical Companies;
Pharmacy Benefit Manager;
Health Care;
Health Care And Treatment;
Health Care Costs;
Health Care Delivery;
Health Care Entrepreneurship;
Telehealth;
Health Equity;
Corporate Strategy;
Social Entrepreneurship;
Equity;
Growth and Development Strategy;
Expansion;
Product Launch;
Customer Value and Value Chain;
Social Enterprise;
Multinational Firms and Management;
Pharmaceutical Industry;
Health Industry;
Africa
- 2022
- White Paper
The American Opportunity Index: A Corporate Scorecard of Worker Advancement
By: Matt Sigelman, Joseph Fuller, Nik Dawson and Gad Levanon
The American Opportunity Index: A Corporate Scorecard of Worker Advancement is a new effort to give companies and other stakeholders a set of robust tools that measure how well major employers are doing in fostering economic mobility for workers and how they could do...
View Details
- July 2022
- Case
David Crane’s Clean(er) Energy Strategy at NRG
By: George Serafeim, Michael W. Toffel and Tom Quinn
In 2015, David Crane was the CEO of NRG, the second-largest energy producer in the United States. NRG got most of its power from fossil fuels, but Crane – hired as CEO in 2003 as NRG emerged from bankruptcy – had invested heavily in alternative energy, loudly...
View Details
- 2022
- Working Paper
A Conceptualization of Sub-Living Wages: Liabilities, Leverage, and Risk
By: Drew Keller, Katie Panella and George Serafeim
Currently the accounting system records employee wages as an expense in the income statement. However, paying below living wages can expose an organization to reputational and operational risks. In this paper, we offer an alternative conceptualization of the issue of...
View Details
- April 2022
- Teaching Note
CVS Health: Prescription for Transformation
By: Rosabeth Moss Kanter and Catarina Martinez
In 2021, new CEO Karen Lynch (named the most powerful woman in business) considered the next transformation phase for CVS Health (a Fortune 5 corporate giant). The 2018 acquisition of Aetna insurance brought her to the company as part of its long evolution from a...
View Details
Keywords:
Health;
COVID-19 Pandemic;
Primary Care;
Leadership;
Change Management;
Women Executives;
Retail;
Pharmacy;
Pharmacy Benefit Manager;
Clinical Trials;
Vaccination;
Acquisition;
Innovation and Invention;
Transformation;
Retail Industry;
Pharmaceutical Industry;
Health Industry;
United States
- March 2022 (Revised January 2023)
- Case
Clara Wu Tsai and Brooklyn Loan Innovation
Philanthropist Clara Wu Tsai is committed to racial equity and investing in Brooklyn-based minority business owners. In the wake of the George Floyd murder, she decides to create a new initiative called the Social Justice Fund and commit an initial $50 million over 10...
View Details
- March 2022 (Revised October 2022)
- Case
Transforming Kimball International, Inc. (A)
By: Lynn S. Paine and Will Hurwitz
Kimball International, Inc. (KII), led by CEO Kristie Juster, and its board of directors, chaired by Kim Ryan, faced critical questions about KII’s future in the spring of 2021. Two years earlier, the board had appointed Juster as the new CEO of KII, a publicly traded,...
View Details
Keywords:
Board Of Directors;
Board Committees;
Board Decisions;
Board Dynamics;
CEO Compensation;
CEO Succession;
Compensation Committee;
Compensation Consultants;
Compensation Design;
Compensation Mix;
Corporate Purpose;
COVID-19;
ESG;
Furniture;
Furniture Industry;
Manufacturing;
Midwest;
Pandemic;
Purpose;
Spin Off;
Strategic Change;
Strategic Decisions;
Strategic Evolution;
Target-setting;
Executive Compensation;
Family Ownership;
Governance;
Restructuring;
Strategy;
Transformation;
Manufacturing Industry;
United States
- March 2022
- Supplement
Transforming Kimball International, Inc. (B)
By: Lynn S. Paine and Will Hurwitz
Supplements the (A) case.
View Details
Keywords:
Board Of Directors;
Board Committees;
Board Decisions;
Board Dynamics;
CEO Compensation;
CEO Succession;
Compensation Committee;
Compensation Consultants;
Compensation Design;
Compensation Mix;
Corporate Purpose;
COVID-19;
ESG;
Furniture;
Furniture Industry;
Manufacturing;
Midwest;
Pandemic;
Purpose;
Spin-off;
Strategic Change;
Strategic Decisions;
Strategic Evolution;
Target-setting;
Executive Compensation;
Family Ownership;
Governance;
Restructuring;
Strategy;
Transformation;
Manufacturing Industry;
United States
- March 2022 (Revised April 2022)
- Teaching Note
France Télécom (A), (B), and (C)
By: Ashley Whillans
This case series discusses the evolution of France Télécom (now Orange) from a national telephone monopoly to a private company. During this process, the company faced numerous challenges including the entry of new competition from other countries and a workforce that...
View Details
- February 2022 (Revised April 2022)
- Case
CVS Health: Prescription for Transformation
By: Rosabeth Moss Kanter and Tuna Cem Hayirli
In 2021, new CEO Karen Lynch (named the most powerful woman in business) considered the next transformation phase for CVS Health (a Fortune 5 corporate giant. The 2018 acquisition of Aetna insurance brought her to the company as part of its long evolution from a...
View Details
- February 2022
- Case
Agora (A)
By: Lindsay N. Hyde, Thomas R. Eisenmann and Tom Quinn
Agora was a civic technology (civic tech) startup founded by Elsa Sze, who wanted to enhance the connection between political officials and their constituents by facilitating virtual “town halls,” making underrepresented voices heard and benefiting elected and...
View Details
- February 2022
- Supplement
Agora (B)
By: Lindsay N. Hyde, Thomas R. Eisenmann and Tom Quinn
This is the conclusion to Agora (A), where founder Elsa Sze decides if she wants to continue investing energy in her civic technology startup.
Agora was a civic technology (civic tech) startup founded by Elsa Sze, who wanted to enhance the connection between...
View Details
- 2022
- Working Paper
The Routledge Handbook of Digital Consumption, Chapter 41: The Internet’s Effects on Consumption: Useful, Harmful, Playful
By: John A. Deighton and Leora Kornfeld
This chapter considers how digital culture has changed over the past decade, as the internet has grown its scope and user base. Billions around the world connect daily to an ever-expanding set of applications. A framework for thinking about digital effects is offered:...
View Details
- 2022
- Book
Deep Purpose: The Heart and Soul of High-Performance Companies
By: Ranjay Gulati
This book offers a compelling reassessment and defense of purpose as a management ethos, documenting the vast performance gains and social benefits that become possible when firms manage to get purpose right. Few business topics have aroused more skepticism in recent...
View Details
- 2021
- Working Paper
The Incidence of the Corporate Income Tax Is Irrelevant for Its (Benefit-Based) Justification
Robust support for corporate income taxation is a puzzle for standard tax theory because the tax’s incidence is uncertain and unreliable. We propose a resolution: if the corporate tax is seen as a benefit-based tax, its normative appeal depends on the correspondence...
View Details
- October 2021 (Revised October 2022)
- Case
The Opioid Settlement and Controversy Over CEO Pay at AmerisourceBergen
By: Suraj Srinivasan and Li-Kuan Ni
In 2020, AmerisourceBergen Corporation, a Fortune 50 company in the drug distribution industry, agreed to settle thousands of lawsuits filed nationwide against the company for its opioid distribution practices that critics alleged had contributed to the nationwide...
View Details
Keywords:
Opioids;
Drug;
Investors;
Shareholder Activism;
Investment Activism;
Executive Compensation;
Corporate Accountability;
Corporate Governance;
Governance Compliance;
Governance Controls;
Risk Management;
Corporate Social Responsibility and Impact;
Business and Shareholder Relations;
Business and Stakeholder Relations;
Legal Liability;
Distribution Industry;
Health Industry;
Pharmaceutical Industry;
United States;
West Virginia;
Tennessee;
Ohio;
Pennsylvania
- 2017
- Working Paper
Does Financial Misconduct Affect the Future Compensation of Alumni Managers?
By: Boris Groysberg, Eric Lin and Georgios Serafeim
We explore how an organization’s financial misconduct may affect pay for former employees not implicated in wrongdoing. Drawing on stigma theory we hypothesize that although such alumni did not participate in the financial misconduct and they had left the organization...
View Details